Type of MS: PPMS
Treatment mode of action: To prevent progression
Number of Subjects: 100
Medication: ocrelizumab
Location: California
Institutions: SC3 Research - Pasadena
Contact Information
Roxanne Cabading, ext. 799
(626) 250 2070
roxanne.cabading@neurosearch-usa.com